Files
Download Full Text (8.3 MB)
Contents
- Retinoic acid/interferon combination shows promising response rates
- Cross-matching test helps find donors for patients in dire need of platelets
- Silicone gel-filled implants: Women should have the option to choose
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
1992
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Lippman, Scott M.; Hong, Waun Ki; Krakoff, Irwin H.; Paredes-Espinoza, Mario; Kavanagh, John J.; Schusterman, Mark A.; Kessler, David; Patten, Bernard; Singletary, S. Eva; Ross, Merrick I.; Ogden, Daryl; Lichtiger, Benjamin; Asfour, Ayman; Tretinoin; Interferons; Carcinoma, Squamous Cell; Antineoplastic Agents; Uterine Cervical Neoplasms; Radiotherapy; Leukemia, Hairy Cell; Sarcoma, Kaposi; Chemoprevention; Breast Implants; Silicone Gels; Mammaplasty; Mastectomy; Blood Platelets; Purpura, Thrombocytopenic; Platelet Transfusion.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Lippman, Scott M. MD; Schusterman, Mark A. M.D.; Singletary, Eva MD; Ross, Merrick I. M.D.; and Ogden, Daryl MS, "OncoLog, Volume 37, Issue 03, July-September 1992" (1992). OncoLog MD Anderson's Report to Physicians (All issues). 39.
https://openworks.mdanderson.org/oncolog/39
Conditions Governing Access
Open
